Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Gervais Bérubé

Gervais Bérubé

Université du Québec à Trois-Rivières Canada

Nadezhda Shchepina

Nadezhda Shchepina

Institute of Perm State University Russia

Sergey Lednev

Sergey Lednev

P.G. Demidov Yaroslavl State University Russia

Victor Guallar

Victor Guallar

Barcelona Supercomputing Center Spain

Catherine Guillou

Catherine Guillou

Unversité de Paris-Saclay France

Yuegang Zuo

Yuegang Zuo

University of Massachusetts Dartmouth USA

Tove Tuntland

Tove Tuntland

Novartis Institute of Biomedical Research USA

Rongshi Li

Rongshi Li

University of Nebraska Medical Center USA

Medicinal Chemistry 2018

About Conference

Conference Series Ltd invites all the participants from all over the world to attend ‘10th World Congress on Medicinal Chemistry’ during June 14-15, 2018 at Barcelona, Spain, The main theme of the conference is Focus on present and future techniques and development in Medicinal Chemistry and Drug design which includes the prompt keynote presentations, Oral talks, Poster presentations, Video Presentations and Exhibitions.

Medicinal Chemistry is a global platform to discuss and learn about Medical research Advances in Medicinal Chemistry, Bioorganic and Medicinal Chemistry, Recent trends in Drug Design and Drug Development, Computational Chemistry, Pharmacology, Organic Chemistry, Analytical Chemistry, Chemical Biology, Anticancer agents in Medicinal Chemistry, Bio organometallic Chemistry and Toxicology, Biopharmaceuticals and Radiopharmaceuticals, Pharmaceutical Industry Trends, Pharmacotoxicology. Conference Series Ltd Conferences has taken the initiation to gather the world class experts both from academic and industry in a common platform.

Medicinal Chemistry focuses on all aspects concerned with the substances of which matter is composed, the investigation of their properties and reactions, and the use of such reactions to form new substances.

Target audience: Chairperson, Director/ Dean, Associate Professors, professors, PhD students and post graduates of Chemistry, Pharmaceuticals, Biology and Physical Sciences, Chemical Biology, Analytical Chemistry, Nano Science, and related fields.

The scientific program includes Keynote & Plenary talks, Video Presentations, Poster Presentations and E-Posters. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry & Pharmacology, Drug discovery software, future med chem and Scientists of Relevant Field.

For abstract submission please: http://medicinalchemistry.pharmaceuticalconferences.com/europe/abstract-submission.php

Email: [email protected]

ConferenceSeries Ltd organises 800+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Market Analysis

Chemistry is the branch of science concerned with the substances of which matter is composed, the investigation of their properties and reactions, and the use of such reactions to form new substances.

Medicinal Chemistry 2018 provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields.

The mission of the Medicinal chemistry 2018 is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.

For these reasons, the School is directed to participants at a graduated and post-graduated level, in chemistry but also in pharmacology or biology, who are keen to explore the interdisciplinary context of current cutting-edge research in medicinal chemistry.

To achieve these very ambitious goals, the Conference series LLC is organized into thematic sessions.

Conference Highlights:

Medicinal Chemistry

Pharmaceutical Sciences

Drug Design and Drug Development

CADD (Computer Aided Drug Design)

Bioorganic and Medicinal Chemistry

Pharmacology and toxicology

 Anticancer agents in Medicinal Chemistry

Analytical Chemistry

 Pharmaceutical Industry

Organic Chemistry

Why to attend???

With members from around the world focused on learning about Chemistry, Medicinal chemistry, Pharmaceutical chemistry, organic and inorganic chemistry; this is your single best opportunity to reach the largest assemblage of participants. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields are hallmarks of this conference.

Target Audience:

Directors, Presidents & CEO’s from companies, Chemical Instrument Vendors Professors and Students from Academia in the study of medicinal chemistry, Pharmaceutical chemistry, Chemistry, Chemical biology, Pharmacology, Analytical and Bioanalytical Sciences. Delegates from various Pharma & Instrumental companies from all over the world.

Market Analysis:

Medicinal Chemistry for Drug Discovery Market: Overview

Over the last decade, industry’s productivity has been declining with rising R&D costs and time taken to reach market. Medicinal chemistry is defined as a focused science that is developed to cover a wide range of fields related with identification, synthesis and drug development for therapeutic applications. This science has evolved from medical chemists focusing on drug target or pathway in mind and league of elaborative chemistry-driven processes to modern generation of high-throughput screening (HTS) libraries that are created by combinatorial chemistry based on few structural distinctions across large drug like scaffolds.

This change was needed because of high attrition rate in pre-clinical and incubation drug development studies because of earlier methods. While the primary task of medicinal chemists has not changed significantly over a period of time, the computational tools and chemicals and perspectives at their clearance or removal have advanced extensively.

The various tools of medicinal chemistry are in silico modeling, structure-based drug design (SBDD), comparative molecular field analysis (CoMFA) or 3D QSAR method. In particular the fragment-based drug design promisingly stands out because of substantial improvements in research and productivity. One of the primary challenges of drug discovery is to design a robust drug that is both safe and effective in a wide range of population. The various drug designing types are structure-based drug design, natural products-based drug design, fragment-based drug design, diversity oriented synthesis and chemo genomics.

Medicinal Chemistry for Drug Discovery Market: Trends

Due to modern technology an alternative approach to the large combichem libraries (10,000 plus molecules) is available, these are smaller focused arrays known as chemo genetic arrays that assists for confining of particular pharmacophore model for specific family to target but considering ADME and drug-like properties. The compound arrays must be synthetically feasible and to minimize the attrition rate in preclinical testing, must also consist of specific properties regarding adsorption, distribution, metabolism, elimination and toxicity (ADMET).

During this process the ADMET constraints established from information mining, in vitro and in vivo studies are often compiled into computational packages to enable chemists to predict the drug-likeliness of a compound.

The recent market trends observed with medicinal chemistry operations are outsourced by most of the pharmaceutical companies because this helps the companies to pace up the research process making it time and cost efficient. The outsourcing trend observed from the North American and European pharmaceutical companies to the companies of developing companies like India, China and Others from Asian continent.

It has estimated that in the field of medicinal chemistry more than $79 million in research funding has spent since 2008. A complete overview of drug designing process has come up with some crucial details that from year 2008 to 2013 the market has a growth with $ 198 Billion and in further this rate may increases to $236 Billion from year 2014 to 2019. Special emphasis is given on computational approaches for drug discovery along with salient features and applications of the software’s used in de novo drug designing.

In the future year of 2020, the revenue budget of drug designing or drug production reveals that the large drug companies are facing the expiry of patents on their best sellers. At the same time they are having trouble inventing new medicines, and this means that the drug industry’s sales may at best tread water and could face some steep drops. The point of market analysis is to see what happens 

Medicinal Chemistry for Drug Discovery Market: Opportunities and Competitive Dynamics

The mightiest challenge in this industry is to reduce the number of drugs that fail in pre-clinical stages, as this facilitates the manufacturer to enter the market with a high priced drug. But since the ADME profiling used in silico and cellular approaches have successfully reduced the attrition rate. According to industry experts currently structure-based drug design has high acceptance followed by fragment-based variation, natural products, while diversity oriented synthesis and chemo genomics have negligible market shares. The top five active therapeutic research areas are cancer, infections, neurological, gastrointestinal, endocrine and cardiovascular.

Drug discovery is expected to be largely practiced at small niche biopharmaceutical companies around the world in the U.K., U.S., Western Europe, Eastern Europe, China, India, Brazil, South Africa and Mexico as investments, time and risks are comparatively less in this operations model than the traditional. Overall the medicinal chemistry has improved all these years with all updated technologies and methodologies.

The importance of small and medium scaled companies will increase in this market as it will reduce the time and cost for a big pharmaceutical company. Hence, in drug discovery medicinal chemistry plays important role but still the accuracy and precision of the study needs to be improved to achieve minimum rejections in the preclinical studies.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

• Market segments and sub-segments

• Market trends and dynamics

• Supply and demand

• Market size

• Current trends/opportunities/challenges

• Competitive landscape

• Technological breakthroughs

• Value chain and stakeholder analysis

The regional analysis covers:

• North America (U.S. and Canada)

• Latin America (Mexico, Brazil, Peru, Chile, and others)

• Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)

• Eastern Europe (Poland, Russia)

• Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)

• Middle East and Africa (GCC, Southern Africa, North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Major Associations in Europe:

American Association of Pharmaceutical Scientists.

Association of the British Pharmaceutical Industry

American Board of Toxicology

Association of Biomolecular Resource Facilities

American Society for Clinical Pharmacology and Therapeutics

Genomics and bioinformatics resources and discussions

European Generic Medicines Association

European Federation for Pharmaceutical Sciences

International Pharmaceutical Federation

The Society for Life Science Professionals.

International Union of Pharmacology

Czech Chemical Society

Italian Chemical Society

American Association for Clinical Chemistry

American Chemical Society

American Institute of Chemists

 Royal Society of Chemistry

Swedish Chemical Society

New Swiss Chemical Society

Spanish Society of Analytical Chemistry

Spanish Royal Society of Chemist

Past Conference Report

Medicinal Chemistry 2017

Medicinal Chemistry 2017

Conferenceseries LLC successfully organized 6th World Congress on Medicinal Chemistry and Drug Design during June 07-08, 2017 at Milan, Italy and received great and fruitful response. Eminent Scientists, Researchers, Pharmacists, Industry Professionals and scholar students has made their resplendent presence and addressed the gathering.

The theme of the conference “Achieving Future Generation Advancements in Medicinal Chemistry and Drug design”

Medicinal Chemistry 2017 Organizing Committee would like to thank the Moderator of the conference, Mr. John Turman, Biogen, USA who contributed a lot for the smooth functioning of this event.


Past Reports  Gallery  

Supported By

Medicinal chemistry Pharmaceutical Analytical Chemistry Chemical Sciences Journal Modern Chemistry & Applications

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


What People Say....

Program/speakers : Interesting, Mix of topics was good and relevant, Nearly all speakers provided a good and science-based talk with little marketing. John Turman of Pfizer did a great job as moderator. Attendees/delegates: Quality professionals from major institutions, The questions and after-talk discussions was excellent.

Speaker

Whitford, Bill, GE Healthcare, USA

I have to say that Medicinal Chemistry 2017 was a great meeting. Presentations were very good and showed high –impact medicinal chemistry research in various domains.

Speaker

Lavrik Olga, Institute of Chemical Biology and Fundamental Medicine, Russia

The conference was good organized and Topics of the conference were very interesting. Thanks everyone for well done work.

Speaker

Maia Merlani, Tbilisi State Medical University, Georgia

I thank you for the opportunity to speak about my research. The congress has been well organized, I has been satisfied for my participation

Speaker

Michele Tonelli, University of Genoa, Italy

Thank you very much for everything regarding the congress are generally good, excellent the hubicación and excellent the talks and coexistence.

Speaker

Q B C Francisco Humberto González Gutiérrez, Universidad de sonora, Mexico